Findlay Park Partners LLP Buys New Position in The Cooper Companies, Inc. $COO

Key Points

• Findlay Park Partners initiated a position of 1.284 million Cooper Companies shares in the second quarter, valued at approximately $92.1 million and representing about 0.66% of the company.
• Cooper Companies exceeded quarterly expectations, reporting $1.21 EPS versus the $1.10 consensus and $1.08 billion in revenue, up 7.9% year over year. Management guided to fiscal 2026 EPS of $4.58–$4.66.
• Analyst sentiment is mixed: the stock has an overall “Hold” rating with a consensus price target of $81.64, while recent targets ranged from $61 to $92 and included both upgrades-positive ratings and a downgrade to “Sell.”

Findlay Park Partners LLP purchased a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,284,000 shares of the medical device company's stock, valued at approximately $92,076,000. Findlay Park Partners LLP owned approximately 0.66% of Cooper Companies as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of the business. Heartland Advisors Inc. acquired a new stake in shares of Cooper Companies during the fourth quarter worth $15,348,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Cooper Companies by 6.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company's stock valued at $34,224,000 after acquiring an additional 23,896 shares during the period. Swedbank AB raised its stake in Cooper Companies by 18.8% in the 4th quarter. Swedbank AB now owns 1,074,029 shares of the medical device company's stock worth $88,027,000 after acquiring an additional 170,000 shares during the last quarter. Capital International Inc. CA raised its stake in Cooper Companies by 22.9% in the 4th quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company's stock worth $9,688,000 after acquiring an additional 22,054 shares during the last quarter. Finally, SEB Asset Management AB acquired a new stake in Cooper Companies during the 1st quarter worth about $22,823,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Up 0.1%

Shares of COO opened at $76.22 on Friday. The company has a market capitalization of $14.87 billion, a price-to-earnings ratio of 64.59, a PEG ratio of 1.99 and a beta of 0.83. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The stock's 50-day moving average price is $71.93 and its 200-day moving average price is $71.16. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies's revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on COO. Stifel Nicolaus cut their price objective on Cooper Companies from $95.00 to $85.00 and set a "buy" rating on the stock in a report on Friday, June 5th. BNP Paribas Exane dropped their target price on Cooper Companies from $95.00 to $92.00 and set an "outperform" rating on the stock in a research report on Monday, June 8th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a report on Wednesday, May 27th. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the stock an "overweight" rating in a research report on Monday, June 1st. Finally, Weiss Ratings cut shares of Cooper Companies from a "hold (c-)" rating to a "sell (d)" rating in a research note on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $81.64.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source